# Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients

> **NCT04686916** · PHASE2 · UNKNOWN · sponsor: **Initiator Pharma** · enrollment: 24 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** IP2018
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04686916
- **Lead sponsor:** Initiator Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-30
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04686916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04686916, "Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04686916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*